Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

  • Siddiqui A
  • Akhtar S
  • Shah Z
  • et al.
30Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It is a known fact that inflammation affects several physiological processes, including the functioning of the central nervous system. Additionally, impairment of lipid mechanisms/pathways have been associated with a number of neurodegenerative disorders and Alzheimer's Disease (AD) is one of them. However, much attention has been given to the link between tau and beta- amyloid hypothesis in AD pathogenesis/prognosis. Increasing evidences suggest that biologically active lipid molecules could influence the pathophysiology of AD via a different mechanism of inflammation. This review intends to highlight the role of inflammatory responses in the context of AD with the emphasis on biochemical pathways of lipid metabolism enzyme, 5-lipoxygenase (5- LO).

Cite

CITATION STYLE

APA

Siddiqui, A., Akhtar, S., Shah, Z., Othman, I., & Kumari, Y. (2020). Inflammation Drives Alzheimer’s Disease: Emphasis on 5-lipoxygenase Pathways. Current Neuropharmacology, 19(6), 885–895. https://doi.org/10.2174/1570159x18666200924122732

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free